deltatrials
Terminated PHASE3 INTERVENTIONAL NCT00176956

Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients

Sponsor: Hordinsky, Maria K., MD

Conditions Dermatitis
Interventions Skin Biopsy
Updated 7 times since 2017 Last updated: Feb 1, 2013 Started: Nov 30, 2002 Primary completion: Jan 31, 2007 Completion: Jan 31, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

IRB approval has lapsed.

A PHASE3 clinical study on Dermatitis, this trial is terminated or withdrawn. The trial is conducted by Hordinsky, Maria K., MD and has accumulated 7 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Study Description(click to expand)

We want to determine whether pediatric heart transplant patients with an atopic dermatitis-like rash report a personal and/or family history of atopy (asthma, allergies and atopic dermatitis). In addition comparisons will be made between the presence of atopy between patients with and without the skin rash. Comparisons will be made of systemic immunosuppressive therapies between patients with and without the atopic dermatitis-like rash. Determination will be made as to whether histologic characterization of a skin biopsy specimen is consistent with AD. Thorough evaluations will be made of patients in the clinic with this rash and the presence of bacterial superinfection will be ruled out.

We want to determine whether pediatric heart transplant patients with an atopic dermatitis-like rash report a personal and/or family history of atopy (asthma, allergies and atopic dermatitis). In addition comparisons will be made between the presence of atopy between patients with and without the skin rash. Comparisons will be made of systemic immunosuppressive therapies between patients with and without the atopic dermatitis-like rash. Determination will be made as to whether histologic characterization of a skin biopsy specimen is consistent with AD. Thorough evaluations will be made of patients in the clinic with this rash and the presence of bacterial superinfection will be ruled out.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Nov 2019 · 17 months · monthly snapshotTerminated~Nov 2019 – ~Jan 2021 · 14 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 19 months · monthly snapshotTerminated~Jan 2026 – present · 3 months · monthly snapshotTerminated

Change History

7 versions recorded
  1. Jan 2026 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Present [monthly]

    Terminated PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  5. Nov 2019 — Jan 2021 [monthly]

    Terminated PHASE3

Show 2 earlier versions
  1. Jun 2018 — Nov 2019 [monthly]

    Terminated PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    First recorded

Nov 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hordinsky, Maria K., MD
Data source: University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations